Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus

Journal of Medical Virology

Volumn 74, Issue 2, 2004, Pages 272-276

  Bonvicini, F ^a   Gallinella, G ^a   Cricca, M ^a   Ambretti, S ^a   Delbarba, S ^a   Musiani, M ^a   Zerbini, M ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Erythrovirus B19; Plasma pool infectivity

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS DNA; VIRUS RNA;

ANTIBODY TITER; ARTICLE; BLOOD; BLOOD TRANSFUSION; CONTROLLED STUDY; DNA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VITRO STUDY; INFECTION; MOLECULAR TYPING; NONHUMAN; PARVOVIRUS; PLASMA; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRAL CONTAMINATION; VIRUS; VIRUS DETECTION; VIRUS EXPRESSION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; BLOOD DONORS; CELL LINE; DNA, VIRAL; DRUG CONTAMINATION; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PLASMA; VIRAL LOAD;

ERYTHROVIRUS;

EID: 4344562769     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20180     Document Type: Article

References (20)

1. Azzi A, Zakrzewska K, Gentilomi G, Musiani M, Zerbini M. 1990. Detection of B19 parvovirus infections by a dot-blot hybridization assay using a digoxigenin-labelled probe. J Virol Method 27:125-134.
2. Brown KE, Young NS, Alving BM, Barbosa LH. 2001. Parvovirus B 19: Implications for transfusion medicine. Transfusion 41:130-135.
3. Daly P, Corcoran A, Mahon BP, Doyle S. 2002. High-sensitivity PCR detection of parvovirus B19 in plasma. J Clin Microbiol 40:1958-1962.
4. Gallinella G, Venturoli S. 1999. B19 virus complete genome. Accession: NC_000883;http://www.ncbi.nlm.nih.gov/cgin/Entrez/framik?db=genome&gi=15097.
5. Gallinella G, Musiani M, Zerbini M, Gentilomi G, Gibellini D, Venturoli S, La Placa M. 1993. Efficient parvovirus B19 DNA purification and molecular cloning. J Virol Method 41:203-212.
6. Gallinella G, Zerbini M, Musiani M, Venturoli S, Gentilomi G, Manaresi E. 1997. Quantitation of parvovirus B19 DNA sequences by competitive PCR: Differential hybridization of the amplicons and immunoenzymatic detection on microplate. Mol Cell Probes 11:127-133.
7. Gallinella G, Manaresi E, Zuffi E, Venturoli S, Bonsi L, Bagnara GP, Musiani M, Zerbini M. 2000. Different patterns of restriction to B19 parvovirus replication in human blast cell lines. Virology 278:361-367.
8. Gallinella G, Moretti E, Nardi G, Zuffi E, Bonvicini F, Bucci E, Musiani M, Zerbini M. 2002. Analysis of B19 virus contamination in plasma pools for manufacturing, by using a competitive polymerase chain reaction assay. Vox Sang 83:324-331.
9. Gentilomi G, Zerbini M, Musiani M, Gallinella G, Gibellini D, Venturoli S, Re MC, Pileri S, Finelli C, La Placa M. 1993. In situ detection of B19 DNA in bone marrow of immunodeficient patients using a digoxigenin-labelled probe. Mol Cell Probes 7:19-24.
10. Guertler L. 2002. Virus safety of human blood, plasma, and derived products. Thromb Res 107:39-45.
11. Koenigbauer UF, Eastlund T, Day JW. 2000. Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion 40:1203-1206.
12. Lynch T. 1999. Human parvovirus B19 trasmission from S/D plasma. Rockville, MD, FDA/CBER Blood Products Advisory Committee, http://www.fda.gov/ ohrms/dockets/ac/99/transcpt/3520t1.rtf.
13. Miyagawa E, Yoshida T, Takahashi H, Yamaguchi K, Nagano T, Kiriyama Y, Okochi K, Sato H. 1999. Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. J Virol Meth 83:45-54.
14. Robertson BH, Erdman DD. 2000. Non-enveloped viruses transmitted by blood and blood products. Dev Biol Stand 102:29-35.
15. Saito T, Munakata Y, Fu Y, Fujii H, Kodera T, Miyagawa E, Ishii K, Sasaki T. 2003. Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction. J Virol Meth 107:81-87.
16. Schmidt I, Blumel J, Seitz H, Willkommen H, Lower J. 2001. Parvovirus B19 DNA in plasma pools and plasma derivatives. Vox Sang 81:228-235.
17. Solheim BG, Rollag H, Svennevig JL, Arafa O, Fosse E, Bergerud U. 2000. Viral safety of solvent/detergent-treated plasma. Transfusion 40:84-90.
18. Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y. 1995. Human parvovirus B 19 infection in blood donors. Vox Sang 69:206-212.
19. Zerbini M, Musiani M. 2003. Human parvoviruses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 8th edition, Vol. II. Washington: ASM Press. pp 1534-1543.
20. Zerbini M, Gallinella G, Manaresi E, Musiani M, Gentilomi G, Venturoli S. 1999. Standardization of a PCR-ELISA assay in serum samples: Diagnosis of Active Parvovirus B19 infection. J Med Virol 59:239-244.